TelyRx Holdings Inc. (TSX:TELY)
2.850
+0.025 (0.88%)
At close: Jul 24, 2026
TelyRx Holdings Revenue
TelyRx Holdings had revenue of $19.39M USD in the quarter ending March 31, 2026, with 313.96% growth. This brings the company's revenue in the last twelve months to $55.39M. In the year 2025, TelyRx Holdings had annual revenue of $42.92M with 350.27% growth.
Revenue (ttm)
$55.39M
Revenue Growth
+350.27%
P/S Ratio
1.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
139.22M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.92M | 33.39M | 350.27% |
| Dec 31, 2024 | 9.53M | 9.51M | 35,207.41% |
| Dec 31, 2023 | 27.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTelyRx Holdings News
- 2 days ago - TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET - Newsfile Corp
- 12 days ago - TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare - PRNewsWire
- 16 days ago - TelyRx Holdings Inc. Announces DTC Eligibility for U.S. Traded Shares - Newsfile Corp
- 16 days ago - TelyRx Holdings Transcript: Global Technology Virtual Investor Conference - Transcripts
- 17 days ago - TelyRx to Present at the Global Technology Virtual Investor Conference July 9, 2026 - Newsfile Corp
- 18 days ago - TelyRx to Present at the Global Technology Virtual Investor Conference July 9th - GlobeNewsWire
- 5 weeks ago - TelyRx Announces Voting Results from Annual General Meeting of Shareholders - Newsfile Corp
- 6 weeks ago - TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy - Newsfile Corp